A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, January 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 11,986 followers.

RT @JournalofExper1: A novel 𝐡𝐮𝐦𝐚𝐧𝐢𝐳𝐞𝐝 𝐅𝐫𝐢𝐳𝐳𝐥𝐞𝐝-7-𝐭𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐚𝐧𝐭𝐢𝐛𝐨𝐝𝐲 enhances antitumor effects of Bevacizumab against #𝐭𝐫𝐢𝐩𝐥𝐞𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 #𝐛𝐫𝐞…

Reply Repost Favourite

RT @JournalofExper1: A novel 𝐡𝐮𝐦𝐚𝐧𝐢𝐳𝐞𝐝 𝐅𝐫𝐢𝐳𝐳𝐥𝐞𝐝-7-𝐭𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐚𝐧𝐭𝐢𝐛𝐨𝐝𝐲 enhances antitumor effects of Bevacizumab against #𝐭𝐫𝐢𝐩𝐥𝐞𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 #𝐛𝐫𝐞…

Reply Repost Favourite

RT @JournalofExper1: A novel 𝐡𝐮𝐦𝐚𝐧𝐢𝐳𝐞𝐝 𝐅𝐫𝐢𝐳𝐳𝐥𝐞𝐝-7-𝐭𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐚𝐧𝐭𝐢𝐛𝐨𝐝𝐲 enhances antitumor effects of Bevacizumab against #𝐭𝐫𝐢𝐩𝐥𝐞𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 #𝐛𝐫𝐞…

Reply Repost Favourite

A novel 𝐡𝐮𝐦𝐚𝐧𝐢𝐳𝐞𝐝 𝐅𝐫𝐢𝐳𝐳𝐥𝐞𝐝-7-𝐭𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐚𝐧𝐭𝐢𝐛𝐨𝐝𝐲 enhances antitumor effects of Bevacizumab against #𝐭𝐫𝐢𝐩𝐥𝐞𝐧𝐞𝐠𝐚𝐭𝐢𝐯𝐞 #𝐛𝐫𝐞𝐚𝐬𝐭𝐜𝐚𝐧𝐜𝐞𝐫 via blocking #Wntβcatenin signaling pathway 💻 https://t.co/Ngw4F3HImM @IREISGufficiale https://t.co/6zaQFisgkB

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.